Related Experiment Video
Updated: Feb 28, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Antibiotic-associated haemorrhagic colitis: not always Clostridium difficile
Olalekan Akanbi1, Nasir Saleem1, Mohanad Soliman1
1Department of Internal Medicine, Presence Saint Joseph Hospital, Chicago, Illinois, USA.
Antibiotic-associated colitis can be caused by Klebsiella oxytoca, not just Clostridium difficile. This case highlights the importance of considering other pathogens in patients with bloody diarrhea after antibiotic use.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Internal Medicine
Background:
- Antibiotic-associated colitis is a common complication of antibiotic therapy.
- Clostridium difficile colitis is the most frequent cause of antibiotic-associated colitis.
- Haemorrhagic colitis presents with bloody diarrhea and abdominal pain.
Observation:
- An 85-year-old woman presented with symptoms of severe gastrointestinal distress, including abdominal pain and mucobloody diarrhea.
- Her condition followed a 5-day course of self-initiated amoxicillin-clavulanic acid.
- Abdominal CT scan showed significant thickening of the ascending and transverse colon.
Findings:
- Stool culture confirmed the presence of Klebsiella oxytoca, a recognized cause of haemorrhagic colitis.
- The patient's symptoms improved with antibiotic cessation and conservative management.
- Colonoscopy was declined, but clinical recovery was achieved.
Implications:
- Clinicians should maintain vigilance for haemorrhagic colitis in patients using antibiotics, even when Clostridium difficile is not suspected.
- Klebsiella oxytoca should be considered as a potential pathogen in antibiotic-associated haemorrhagic colitis.
- Prompt diagnosis and management, including antibiotic withdrawal, are crucial for patient recovery.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.